» Articles » PMID: 37171503

Applied Coronary Physiology for Planning and Guidance of Percutaneous Coronary Interventions. A Clinical Consensus Statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology

Abstract

The clinical value of fractional flow reserve and non-hyperaemic pressure ratios are well established in determining an indication for percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD). In addition, over the last 5 years we have witnessed a shift towards the use of physiology to enhance procedural planning, assess post-PCI functional results, and guide PCI optimisation. In this regard, clinical studies have reported compelling data supporting the use of longitudinal vessel analysis, obtained with pressure guidewire pullbacks, to better understand how obstructive CAD contributes to myocardial ischaemia, to establish the likelihood of functionally successful PCI, to identify the presence and location of residual flow-limiting stenoses and to predict long-term outcomes. The introduction of new functional coronary angiography tools, which merge angiographic information with fluid dynamic equations to deliver information equivalent to intracoronary pressure measurements, are now available and potentially also applicable to these endeavours. Furthermore, the ability of longitudinal vessel analysis to predict the functional results of stenting has played an integral role in the evolving field of simulated PCI. Nevertheless, it is important to have an awareness of the value and challenges of physiology-guided PCI in specific clinical and anatomical contexts. The main aim of this European Association of Percutaneous Cardiovascular Interventions clinical consensus statement is to offer up-to-date evidence and expert opinion on the use of applied coronary physiology for procedural PCI planning, disease pattern recognition and post-PCI optimisation.

Citing Articles

Completeness, timing, and guidance of percutaneous coronary intervention for myocardial infarction and multivessel disease: a systematic review and network meta-analysis.

Laudani C, Occhipinti G, Greco A, Spagnolo M, Giacoppo D, Capodanno D EuroIntervention. 2025; 21(4):e203-e216.

PMID: 39962946 PMC: 11809220. DOI: 10.4244/EIJ-D-24-00814.


Long-term outcomes after percutaneous coronary intervention versus coronary artery bypass grafting in women, a meta-analysis.

Perez-Camargo D, Campelos-Fernandez P, Travieso A, Montero-Cruces L, Carnero-Alcazar M, Olmos-Blanco C J Cardiothorac Surg. 2024; 19(1):666.

PMID: 39707512 PMC: 11660439. DOI: 10.1186/s13019-024-03167-y.


Coronary angiography: a review of the state of the art and the evolution of angiography in cardio therapeutics.

Gurav A, Revaiah P, Tsai T, Miyashita K, Tobe A, Oshima A Front Cardiovasc Med. 2024; 11:1468888.

PMID: 39654943 PMC: 11625592. DOI: 10.3389/fcvm.2024.1468888.


Coronary Physiology to Guide Percutaneous Coronary Intervention: Why, When, and How.

Escaned J, Petraco R, Fearon W J Soc Cardiovasc Angiogr Interv. 2024; 3(9):102198.

PMID: 39575212 PMC: 11576379. DOI: 10.1016/j.jscai.2024.102198.


Fractional Flow Reserve Implications for Clinical Decision Making in Coronary Artery Disease.

Grib A, Abras M, Surev A, Grib L Life (Basel). 2024; 14(10).

PMID: 39459626 PMC: 11509863. DOI: 10.3390/life14101326.


References
1.
Neleman T, van Zandvoort L, Tovar Forero M, Masdjedi K, M R Ligthart J, Witberg K . FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: The FFR REACT Trial. JACC Cardiovasc Interv. 2022; 15(16):1595-1607. DOI: 10.1016/j.jcin.2022.06.018. View

2.
Gohmann R, Pawelka K, Seitz P, Majunke N, Heiser L, Renatus K . Combined cCTA and TAVR Planning for Ruling Out Significant CAD: Added Value of ML-Based CT-FFR. JACC Cardiovasc Imaging. 2021; 15(3):476-486. DOI: 10.1016/j.jcmg.2021.09.013. View

3.
Patel M, Jeremias A, Maehara A, Matsumura M, Zhang Z, Schneider J . 1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI Trial. JACC Cardiovasc Interv. 2022; 15(1):52-61. DOI: 10.1016/j.jcin.2021.09.042. View

4.
Zelis J, Tonino P, Pijls N, De Bruyne B, Kirkeeide R, Gould K . Coronary Microcirculation in Aortic Stenosis: Pathophysiology, Invasive Assessment, and Future Directions. J Interv Cardiol. 2020; 2020:4603169. PMC: 7396014. DOI: 10.1155/2020/4603169. View

5.
Ahmad Y, Gotberg M, Cook C, Howard J, Malik I, Mikhail G . Coronary Hemodynamics in Patients With Severe Aortic Stenosis and Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: Implications for Clinical Indices of Coronary Stenosis Severity. JACC Cardiovasc Interv. 2018; 11(20):2019-2031. PMC: 6197079. DOI: 10.1016/j.jcin.2018.07.019. View